PLK4 (Polo-Like Kinase 4) is a serine/threonine protein kinase that serves as the master regulator of centriole duplication, playing a critical role in microtubule organization, ciliogenesis, and cell cycle progression. As a member of the Polo-like kinase family, PLK4 has unique functions in controlling centriole copy number and ensuring proper mitotic spindle formation. [1] While PLK4 is primarily studied in the context of cell division and cancer, emerging evidence suggests important roles in post-mitotic neurons and neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Amyotrophic Lateral Sclerosis (ALS).
[^2]
[^3]
[^4]
| Symbol | PLK4 |
|---|
| Full Name | Polo-Like Kinase 4 |
| Aliases | SAK, STK18 |
| Chromosomal Location | Chr4q28.1 |
| NCBI Gene ID | 10733 |
| Ensembl ID | ENSG00000142792 |
| UniProt ID | Q9Y5A9 |
| Protein Class | Serine/threonine protein kinase, Polo-like kinase family |
¶ Protein Structure and Function
The PLK4 protein contains several key structural domains: [2]
- N-terminal Kinase Domain: Catalytic serine/threonine kinase domain
- Polo Box Domain (PBD): C-terminal polo boxes that mediate substrate recognition and localization
- Leucine Zipper: Involved in protein-protein interactions
- HAUS Algorithm Domain: For proper centrosome function
PLK4 performs several critical molecular functions:
- Centriole Duplication: Acts as the master regulator ensuring one centriole per cell cycle
- Kinase Activity: Phosphorylates downstream targets to promote centriole formation
- Cell Cycle Regulation: Controls G1/S transition and mitotic entry
- Ciliogenesis: Required for primary cilia formation in interphase cells
¶ Key Pathways and Interactions
PLK4 interacts with key cell cycle regulators:
- STIL: Critical co-factor for centriole duplication
- SAS-6: Central scaffold for centriole assembly
- CPAP: Centriolar pore-like structure protein
- CDK2: Cell division kinase regulating G1/S transition
- AURKA: Aurora kinase A, coordinates centriole maturation
- Centriole Cohesion: PLK4 regulates centriole separation
- Spindle Orientation: Controls mitotic spindle assembly
- Microtubule Anchoring: Ensures proper microtubule organization
PLK4 is expressed in the central nervous system:
- Neural Progenitor Cells: High expression during active proliferation
- Neurons: Lower expression in mature neurons (post-mitotic)
- Astrocytes: Moderate expression
- Microglia: Lower expression
PLK4 mutations cause primary microcephaly: [3]
- Autosomal Recessive Inheritance: Biallelic mutations lead to severe microcephaly
- Mechanism: Impaired neural progenitor cell division during brain development
- Phenotype: Reduced brain size, intellectual disability
PLK4 dysfunction may contribute to Alzheimer's disease pathogenesis:
- Centrosome Dysfunction: Impaired centriole function may affect neuronal polarity
- Cell Cycle Re-entry: Some evidence suggests neurons attempt cell cycle re-entry in AD
- Tau Pathology: PLK4 may interact with tau phosphorylation pathways
- Therapeutic Implications: PLK4 modulators may have neuroprotective potential
In Parkinson's disease:
- Dopaminergic Neuron Development: PLK4 important for development of substantia nigra neurons
- Cellular Stress Response: PLK4 may respond to oxidative stress in neurons
In ALS:
- Motor Neuron Development: PLK4 critical for motor neuron specification
- Axonal Transport: Centrosome function may affect axonal transport
PLK4 is dysregulated in multiple cancers: [4]
- Oncogenic Function: Overexpression in various tumor types
- Genomic Instability: PLK4 alterations contribute to aneuploidy
- Therapeutic Target: PLK4 inhibitors being developed for cancer therapy
- PLK4 Inhibitors: Several small molecules inhibit PLK4 kinase activity
- Cancer Therapy: PLK4 as potential therapeutic target in cancer
- Microcephaly Treatment: Gene therapy approaches for PLK4 mutations
- Neuroprotection: Modulating PLK4 for neurodegenerative diseases
Key protein interactions include:
- STIL: Critical co-factor for centriole duplication
- SAS6: Centriolar scaffold protein
- CPAP: Centriolar protein
- CDK2: Cell cycle kinase
- AURKA: Aurora kinase A
- Plk4-/- mice: Embryonic lethal, severe developmental defects
- Heterozygous mice: Reduced centriole number, cancer predisposition
- PLK4 overexpression: Centrosome amplification, genomic instability
- PLK4 deficiency: Microcephaly phenotype